Journal of Cancer Clinical Trials

Department of Cancer Clinical Research, University of Valencia, 46010 Valencia, Spain

Publications

• Mini Review   
  The Mechanisms of Action and Emerging Novel Views on SGLT-2 Inhibitors in the Treatment of Cancer
  Author(s): Ava Moreno*
  
  Sodium-Glucose Co-Transporter-2 (SGLT-2) inhibitors, originally developed for managing diabetes mellitus, have recently garnered attention for their potential anti-cancer properties. This comprehensive review explores the mechanisms of action of SGLT-2 inhibitors and examines emerging novel perspectives on their role in cancer treatment. We delve into the metabolic alterations induced by these inhibitors, their impact on the tumor microenvironment, and their effects on cancer cell proliferation and survival. Furthermore, we discuss recent preclinical and clinical studies highlighting the therapeutic potential of SGLT-2 inhibitors in various cancer types. This article aims to provide a holistic understanding of the current state of research and future directions for SGLT-2 inhibitors in oncology... Read More»
  DOI: 10.37421/2577-0535.2024.9.249

  Abstract HTML PDF